Troisi Mario, Del Prete Salvatore, Troisi Salvatore, Marasco Daniela, Rinaldi Michele, Costagliola Ciro
Eye Clinic, Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, 80131 Naples, Italy.
Service Biotech s.r.l., 80121 Naples, Italy.
Biomedicines. 2024 Aug 23;12(9):1945. doi: 10.3390/biomedicines12091945.
The authors performed an ex vivo and in vivo evaluation of the ultrastructural effects on the conjunctival epithelial cells of a new multiple-action tear substitute containing cross-linked hyaluronic acid, lipids and trehalose (Trimix), using scanning electron microscopy (SEM) with conjunctival impression cytology. The ex vivo study highlights the persistence and distribution of the product at 5 and 60 min on a monolayer of conjunctival epithelial cells and an increase in microvilli density at the 60 min evaluation. In vivo examination was conducted on three subjects with different grades of ocular surface inflammation, treated with one drop of the product twice daily for thirty days. At the baseline (T) and twelve hours after the last administration of the tear drop (T), impression cytology of the upper bulbar conjunctiva for SEM evaluation of conjunctival epithelial cells was carried out. Slit lamp examination (SLE), corneal and conjunctival Fluotest, tear film break-up time (TBUT), and ocular surface disease index (OSDI) questionnaires were also performed to correlate the ultrastructural results with the clinical findings. After 30 days of treatment, a significant improvement in all clinical and symptomatic parameters and in the condition of the ocular surface was detected, with microvillar regeneration and strengthening in all the patients, and a complete restoration in 2/3 of them. The persistence and distribution of the product on the epithelial cells was also noted 12 h after the last administration. The results, therefore, suggest a marked epitheliotropic effect along with a high residence time of the tear substitute.
作者使用扫描电子显微镜(SEM)结合结膜印迹细胞学技术,对一种含有交联透明质酸、脂质和海藻糖的新型多效性泪液替代物(Trimix)对结膜上皮细胞的超微结构影响进行了体外和体内评估。体外研究突出了该产品在结膜上皮细胞单层上5分钟和60分钟时的持久性和分布情况,以及在60分钟评估时微绒毛密度的增加。对三名患有不同程度眼表炎症的受试者进行了体内检查,每天两次,每次一滴该产品,持续治疗30天。在基线期(T)和最后一次滴入泪液后12小时(T),对上睑结膜进行印迹细胞学检查,用于对结膜上皮细胞进行SEM评估。还进行了裂隙灯检查(SLE)、角膜和结膜荧光素染色、泪膜破裂时间(TBUT)以及眼表疾病指数(OSDI)问卷调查,以将超微结构结果与临床发现相关联。治疗30天后,所有临床和症状参数以及眼表状况均有显著改善,所有患者均出现微绒毛再生和增强,其中2/3的患者完全恢复。在最后一次给药12小时后,还观察到该产品在上皮细胞上的持久性和分布情况。因此,结果表明该泪液替代物具有显著的亲上皮效应以及较长的停留时间。